Cargando…

Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients

BACKGROUND: Chronic inflammation is frequently observed on histological analysis of malignant and non-malignant prostate specimens. It is a suspected supporting factor for prostate diseases and their progression and a main cause of false positive PSA tests in cancer screening. We hypothesized that i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schlick, Bettina, Massoner, Petra, Lueking, Angelika, Charoentong, Pornpimol, Blattner, Mirjam, Schaefer, Georg, Marquart, Klaus, Theek, Carmen, Amersdorfer, Peter, Zielinski, Dirk, Kirchner, Matthias, Trajanoski, Zlatko, Rubin, Mark A., Müllner, Stefan, Schulz-Knappe, Peter, Klocker, Helmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749310/ https://www.ncbi.nlm.nih.gov/pubmed/26863016 http://dx.doi.org/10.1371/journal.pone.0147739

Ejemplares similares

Mathematical models for translational and clinical oncology
por: Gallasch, Ralf, et al.
Publicado: (2013)

TIminer: NGS data mining pipeline for cancer immunology and immunotherapy
por: Tappeiner, Elias, et al.
Publicado: (2017)

Bioinformatics for cancer immunology and immunotherapy
por: Charoentong, Pornpimol, et al.
Publicado: (2012)

The colorectal cancer immune paradox revisited
por: Angelova, Mihaela, et al.
Publicado: (2015)

Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction
por: Mlecnik, Bernhard, et al.
Publicado: (2010)

Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis
por: Heidegger, Isabel, et al.
Publicado: (2014)

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer()
por: Heidegger, Isabel, et al.
Publicado: (2013)

High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer
por: Tymoszuk, Piotr, et al.
Publicado: (2014)

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
por: Bindea, Gabriela, et al.
Publicado: (2009)

Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo
por: Ofer, Philipp, et al.
Publicado: (2015)

Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution
por: Efremova, Mirjana, et al.
Publicado: (2018)

EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205
por: Massoner, P, et al.
Publicado: (2014)

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy
por: Angelova, Mihaela, et al.
Publicado: (2015)

OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation
por: Schöpf, Bernd, et al.
Publicado: (2020)

Identification of microRNA-mRNA functional interactions in UVB-induced senescence of human diploid fibroblasts
por: Greussing, Ruth, et al.
Publicado: (2013)

Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer
por: Schaefer, G, et al.
Publicado: (2013)

Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis
por: Vordenbäumen, Stefan, et al.
Publicado: (2016)

Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer
por: Heidegger, Isabel, et al.
Publicado: (2022)

Characterization of Transcriptional Changes in ERG Rearrangement-Positive Prostate Cancer Identifies the Regulation of Metabolic Sensors Such as Neuropeptide Y
por: Massoner, Petra, et al.
Publicado: (2013)

Aggregation of the Protein TRIOBP-1 and Its Potential Relevance to Schizophrenia
por: Bradshaw, Nicholas J., et al.
Publicado: (2014)

Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer
por: Massoner, P, et al.
Publicado: (2010)

Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia
por: Leidinger, Petra, et al.
Publicado: (2015)

Putative Prostate Cancer Risk SNP in an Androgen Receptor‐Binding Site of the Melanophilin Gene Illustrates Enrichment of Risk SNPs in Androgen Receptor Target Sites
por: Bu, Huajie, et al.
Publicado: (2015)

SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG
por: Shoag, Jonathan, et al.
Publicado: (2017)

Novel Prostate Cancer Biomarkers Derived from Autoantibody Signatures()
por: Schipper, Matthew, et al.
Publicado: (2015)

NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division
por: Borst, Linda, et al.
Publicado: (2021)

Inherited determinants of early recurrent somatic mutations in prostate cancer
por: Romanel, Alessandro, et al.
Publicado: (2017)

Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program
por: Heidegger, Isabel, et al.
Publicado: (2015)

Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer
por: Wallukat, Gerd, et al.
Publicado: (2020)

5-alpha-reductase and the development of the human prostate
por: Radmayr, C., et al.
Publicado: (2008)

Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients
por: Zenzmaier, Christoph, et al.
Publicado: (2011)

SPOP mutation leads to genomic instability in prostate cancer
por: Boysen, Gunther, et al.
Publicado: (2015)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Quantifying tumor-infiltrating immune cells from transcriptomics data
por: Finotello, Francesca, et al.
Publicado: (2018)

Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model
por: Mühlberger, Nikolai, et al.
Publicado: (2017)

Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival
por: Abdulrahman, Ziena, et al.
Publicado: (2022)

Profiling of IgG antibodies targeting unmodified and corresponding citrullinated autoantigens in a multicenter national cohort of early arthritis in Germany
por: Vordenbäumen, Stefan, et al.
Publicado: (2020)

Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008
por: Oberaigner, Willi, et al.
Publicado: (2011)

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer
por: Puhr, M, et al.
Publicado: (2016)

The influence of PSA autoantibodies in prostate cancer patients: a prospective clinical study-II
por: Nakajima, Kosei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kq3atm9avg60ivugjqo9u51n9v